CURRENT OPINION IN STRUCTURAL BIOLOGY is a premier journal published by CURRENT BIOLOGY LTD that serves as a critical platform for disseminating comprehensive reviews and the latest insights into the field of structural biology. With an impressive impact factor and ranked in the top quartile (Q1) in both Molecular Biology and Structural Biology categories, this journal exemplifies excellence in its scope and academic rigor. Researchers and professionals benefit from its insightful articles that cover cutting-edge developments, methodological advancements, and the implications of structural biology in various biological contexts. As part of the esteemed Current Biology series, the journal is committed to enriching the scientific community's understanding of biomolecular structures and their functions. Based in the United Kingdom and indexed in Scopus with high rankings in multiple relevant fields, CURRENT OPINION IN STRUCTURAL BIOLOGY remains an essential resource for scholars at every stage of their academic journey, from students to seasoned researchers, ensuring the ongoing progress of knowledge in this dynamic field.

ACS Bio & Med Chem Au, published by the esteemed American Chemical Society, stands at the forefront of interdisciplinary research within the realms of biochemistry, drug discovery, pharmaceutical sciences, and molecular biology. With an impressive Impact Factor indicative of its rigorous academic standards and significant contributions to the field, this open-access journal is committed to disseminating high-quality research that drives innovation and advancements in biosciences and medicinal chemistry. Since its inception in 2021, the journal has rapidly earned recognition, achieving a commendable Q1 ranking in multiple categories, including Biochemistry, Drug Discovery, and Pharmaceutical Science, while also making strides in Molecular Biology. Researchers, professionals, and students alike can explore pioneering studies that bridge gaps between laboratory research and clinical applications, fostering collaborative efforts towards novel therapeutic strategies. With a focus on enhancing accessibility and engagement within the scientific community, ACS Bio & Med Chem Au is poised to impact the future of biomedical research significantly.

BRIEFINGS IN BIOINFORMATICS is a premier academic journal dedicated to the dynamic field of bioinformatics, published by Oxford University Press. With a prestigious standing reflected in its Q1 quartile rankings in both Information Systems and Molecular Biology, this journal serves as an essential resource for researchers, professionals, and students eager to explore the intersection of biology and computational sciences. The journal not only publishes high-impact research articles but also reviews and critical commentaries that push the boundaries of understanding in bioinformatics. As it converges its objectives towards fostering innovation and knowledge dissemination from 2000 to 2024, BRIEFINGS IN BIOINFORMATICS offers rich insights that remain pivotal to advancements in genomic studies, data integration, and computational tools. Its ranking in the top percentiles of Scopus—30th among 394 in Computer Science and 44th among 410 in Molecular Biology—underscores the journal's influential presence in the academic community. Engaging with the latest research and trends, this journal is integral for anyone invested in the future of life sciences and data analytics.

The International Journal of Biological Macromolecules, published by Elsevier, is a premier journal in the field of biological sciences, distinguished for its rigorous peer-review process and commitment to advancing research in biochemistry, molecular biology, and structural biology. With a Q1 categorization in multiple disciplines, including biochemistry and molecular biology, and an impressive Scopus ranking positioning it among the top echelons of its field, this journal is essential for researchers and professionals dedicated to exploring the complex interactions and applications of macromolecules. The journal, which has been publishing significant findings since 1979, provides a vital platform for disseminating innovative research that addresses critical challenges in various sectors such as medicine, agriculture, and materials science. Though it does not currently offer open access options, its impact on the scientific community is reflected in its H-index and percentile rankings, placing it firmly within the top tiers of its classification. By fostering a deeper understanding of biological macromolecules, this journal continues to contribute significantly to scientific knowledge and technological advancement.

The Journal of Structural Biology-X, published by Elsevier, is a leading open-access journal dedicated to advancing the field of structural biology. Launched in 2019, it has quickly established itself as a vital resource for researchers, professionals, and students, boasting a prestigious Q1 ranking in Structural Biology for 2023 and achieving an impressive Scopus rank of #19 out of 49 in the biochemistry, genetics, and molecular biology category. With an E-ISSN of 2590-1524, this journal emphasizes accessibility and collaboration by providing open access to its comprehensive collection of research articles, reviews, and cutting-edge methodologies. The scope of the journal encompasses significant themes within structural biology, including protein structure, molecular interactions, and imaging techniques, facilitating interdisciplinary dialogue and innovation. Join the global community of scientists and contribute to the body of knowledge that propels our understanding of molecular architecture through the Journal of Structural Biology-X.

FEBS Open Bio is a leading open-access journal published by Wiley, dedicated to advancing our understanding of biochemistry, genetics, and molecular biology. Since its inception in 2011, this journal has provided a robust platform for researchers to share their findings with a wider audience, ensuring the dissemination of high-quality scientific knowledge. With an impact factor reflecting its stature in its field, FEBS Open Bio is ranked #77 out of 221 in general biochemistry, genetics, and molecular biology, placing it in the 65th percentile among its peers. This journal serves as an essential resource for professionals, researchers, and students alike, fostering collaboration and innovation within the scientific community. The commitment to open access not only enhances visibility but also promotes transparency in research, making it a vital contributor to the ongoing dialogue in biochemical and molecular biological sciences. For those looking to stay at the forefront of research developments, FEBS Open Bio is a key publication addressing the latest trends and discoveries in the field.

PROTEINS - STRUCTURE FUNCTION AND BIOINFORMATICS, published by WILEY, is a leading journal in the fields of biochemistry, molecular biology, and structural biology, recognized for its significant contribution to protein research since its inception in 1986. With its impressive rankings in the Q1 category for Biochemistry and Q2 for both Molecular Biology and Structural Biology in 2023, the journal serves as an essential resource for researchers and professionals seeking to explore the intricate relationships between protein structures and their functions. The journal, based in the United States, operates without an Open Access model, ensuring a curated selection of high-quality peer-reviewed articles that drive innovation and collaboration in the scientific community. Engaging with the robust content of PROTEINS not only bolsters academic scholarship but also opens avenues for groundbreaking discoveries that are pivotal in the advancing field of bioinformatics.

NATURE STRUCTURAL & MOLECULAR BIOLOGY is a leading journal published by NATURE PORTFOLIO, dedicated to advancing the field of molecular and structural biology since its inception in 1998. With an impressive impact factor that places it in the Q1 quartile across both the Molecular Biology and Structural Biology categories, this journal is pivotal for researchers and professionals seeking to publish innovative and high-impact results. Its Scopus ranking further highlights its elite status, with a remarkable 98th percentile for Structural Biology and 95th for Molecular Biology. While the journal does not currently offer open access, it continues to foster a rich discourse among scientists by providing a platform for the dissemination of groundbreaking research. Located in the United Kingdom and operated from Berlin, the journal's commitment to excellence positions it as an indispensable resource for students, researchers, and practitioners in the realms of biochemistry, genetics, and molecular biology.

Acta Crystallographica Section F-Structural Biology Communications, published by the International Union of Crystallography, serves as a crucial platform for researchers in the field of structural biology. Established in 2014, this journal focuses on the dissemination of high-quality research regarding the crystallographic methods and structural analyses of biological macromolecules. Although currently positioned in various category quartiles including Q3 in Biochemistry, Biophysics, and Genetics, and even achieving Q2 in Condensed Matter Physics, the journal continually aims to enhance its influence and reach within the scientific community. The journal is an essential resource for professionals and students alike, providing insights into cutting-edge research and methodologies that can advance our understanding of complex biological systems. Accessibility is facilitated through robust online publishing platforms, although it remains beyond the open access model. Located in the United Kingdom, Acta Crystallographica Section F is dedicated to promoting the integrity of structural biology research and fostering a collaborative scholarly environment.

Journal of Biochemistry, published by Oxford University Press, is a prestigious academic journal that has been at the forefront of biochemical research since its inception in 1922. With an ISSN of 0021-924X and an E-ISSN of 1756-2651, this journal serves as a platform for disseminating high-quality research in the fields of biochemistry, molecular biology, and medicine, holding impressive rankings such as Q2 in Biochemistry and Medicine (miscellaneous) in 2023. As of 2024, the journal continues to explore significant topics in these areas, offering valuable insights for researchers, professionals, and students alike. The journal does not currently offer open access, but it remains a vital resource for anyone in the biochemical community seeking to stay updated on the latest discoveries and advancements. With its rich history and dedication to scientific excellence, the Journal of Biochemistry is an indispensable part of the scholarly landscape.